InforCapital
Startup Fundraising

MetaBIX Biotech Raises $1.3M for Agtech Surveillance

MetaBIX Biotech secures $1.3M extension round from Dalus Capital and EWA Capital to scale its AI-driven biosurveillance platform in Brazil.

AM
Alvaro de la Maza

Partner at Aninver

Key Takeaways

  • metaBIX Biotech raised $1.3M (Extension) from Dalus Capital, EWA Capital, TheBoard Peru, Angel Hub, AIR Capital, Danta Fund.
  • Sector: Agriculture, Agribusiness & Agtech, Biotechnology & Life Sciences, Artificial Intelligence (AI).
  • Geography: Uruguay, Brazil.

Analysis

Uruguayan deep tech innovator, metaBIX Biotech, has successfully closed an additional funding round, bringing in $1.3 million. This capital infusion was led by prominent venture firms Dalus Capital and EWA Capital, with significant participation from existing backers including TheBoard Peru, Angel Hub, AIR Capital, and Danta Fund. This latest investment follows a prior $1 million round concluded in October 2025, underscoring sustained investor confidence in the company's disruptive approach to biosecurity.

The core of metaBIX Biotech's offering is an advanced environmental biosurveillance platform. This sophisticated system is engineered to proactively identify potential disease outbreaks within livestock production environments and to detect contamination risks throughout the intricate food supply chain. By integrating non-intrusive environmental monitoring techniques with powerful AI-driven predictive analytics, the company is fundamentally reshaping animal health management, shifting the paradigm from a reactive response model to a truly preventive strategy.

This new funding is strategically earmarked for accelerating metaBIX Biotech's commercial expansion, with a primary focus on the significant Brazilian market. The company has already established working relationships with major agricultural producers in Brazil and is actively conducting field validations across large-scale farming operations. This groundwork is crucial for demonstrating the platform's efficacy and scalability in one of the world's largest agricultural economies.

Laura Macció, co-founder and CEO of metaBIX Biotech, articulated the company's strategic vision, stating, "We are transitioning from the crucial phase of technology validation to actively scaling our global impact. Brazil is set to become our foundational market in 2026 as we diligently forge strategic alliances across key international economies." This statement highlights the company's ambition to establish a global footprint in agricultural biosecurity infrastructure.

The Agtech sector, particularly solutions focused on disease prevention and food safety, is experiencing robust growth. Global spending on agricultural technology is projected to reach hundreds of billions of dollars in the coming years, driven by increasing demand for sustainable food production, heightened regulatory scrutiny, and the persistent threat of zoonotic diseases. metaBIX Biotech's AI-powered predictive analytics directly addresses these critical market needs, offering a compelling value proposition for producers and regulators alike.

With established operations spanning Latin America and extending into Asia, metaBIX Biotech is strategically positioning its platform as essential infrastructure for global agricultural biosecurity. The company's success in attracting diverse investor groups, from early-stage venture capital to established angel networks, signals strong market validation for its innovative technology and its potential to significantly mitigate economic losses and public health risks associated with animal agriculture and food production.